Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial

被引:0
|
作者
Ki Wook Yun
Hoan Jong Lee
Jin Han Kang
Byung Wook Eun
Yae-Jean Kim
Kyung-Hyo Kim
Nam Hee Kim
Young Jin Hong
Dong Ho Kim
Hwang Min Kim
Sung-Ho Cha
机构
[1] Seoul National University College of Medicine,Department of Pediatrics
[2] Chung-Ang University College of Medicine,Department of Pediatrics
[3] The Catholic University of Korea,Department of Pediatrics, College of Medicine
[4] Eulji University School of Medicine,Department of Pediatrics, Eulji General Hospital
[5] Sungkyunkwan University School of Medicine,Departments of Pediatrics, Samsung Medical Center
[6] Ewha Womans University,Department of Pediatrics, School of Medicine
[7] Inje University College of Medicine,Department of Pediatrics, Ilsan Paik Hospital
[8] Inha University College of Medicine,Department of Pediatrics
[9] Korea Cancer Center Hospital,Department of Pediatrics
[10] Yonsei University Wonju College of Medicine,Department of Pediatrics
[11] Kyunghee University,Department of Pediatrics, College of Medicine
来源
关键词
Japanese encephalitis; Vaccine; Vero cells; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 21 条
  • [21] A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age
    Eun, Byung Wook
    Lee, Taek Jin
    Lee, Jina
    Kim, Ki Hwan
    Kim, Dong Ho
    Jo, Dae Sun
    Shin, Sun Hee
    Kim, Hun
    Kim, Kyung-Ho
    Kim, Yun-Kyung
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (09) : E209 - E215